Insider buying last 90 days
No open-market insider purchases were filed for GL in the last 90 days.
From Form 4 filings, dated to when each was filed.
Sep 28 close
Globe Life shares have pulled back 12.8% from their 52-week high, though the stock has outperformed the financial services sector year to date and over the past 52 weeks, attributed to steady premium growth and rising investment income. Health premium growth has strengthened the 2026 outlook, with health premiums up 16% year-over-year in the second quarter, driven by United American and Family Heritage. Separately, EVP and Chief Investment Officer Robert Hensley sold over $1.7 million worth of stock on 22 September 2026 after exercising employee stock options, a transaction disclosed alongside routine Form 4 and Form 144 filings.
GL closed at $166.69, down 0.2%, with the close sitting between its 50-day average of $175.78 and 200-day average of $156.84. The GekkoIndex reads 68.4, placing the stock in the Accumulation zone, up 8.3 over the past five sessions. Price sits 8.9% below Gekko Fair Value of $183.03.
The next earnings date falls on 28 October 2026, 29 days out and just beyond a typical 20-trading-day hold; the prior quarter saw EPS of $3.43 against an estimate of $3.48, with a 2% reaction, and beats have occurred in 5 of the last 8 quarters. Insider, Congress and unusual options activity show no data in their respective windows. Seasonality over the next 20 trading days has averaged +2.1% across 5 years, rising in 4 of them. Analyst consensus among 9 firms stands at 7 buy and 2 hold, with a consensus target of $193.91.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Globe Life scores 4 supportive, 1 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
4 supportive1 mixed0 headwinds
Averages disagree
Close $166.69 sits between the 50-day ($175.78) and 200-day ($156.84) averages, or the averages disagree.
See the chart68.4, Accumulation
Reading 68.4 is in the Accumulation zone.
See the GekkoIndex8.9% below
Price is 8.9% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 29 days
Next report Oct 28, 2026, 29 days away — outside a typical 20-trading-day hold.
See earnings+2.1% on average
From this point in the calendar, the next 20 trading days averaged +2.1% over 5 years, rising in 4 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Globe Life closed at $166.69 on Sep 28, 2026, +16.5% over the past year, inside a 52-week range of $127.85 to $191.55.
Use the left and right arrow keys to read daily values.
Put GL on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Globe Life provides life insurance, supplemental health coverage, and annuity products, with a focus on serving households in the lower-middle to middle-income range across the United States. Its life insurance lineup includes whole life and term life policies, while its health-related offerings cover Medicare supplements, critical illness protection, and accident coverage. The annuity business includes both single-premium and flexible-premium deferred options.
The company runs its business through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. This structure separates its core insurance products from the investment activities that support them, giving a clearer view of how each part of the business contributes to results.
Globe Life traces its founding to 1979 and operates out of McKinney, Texas. It previously carried the name Torchmark Corporation before adopting its current name in August 2019. Its shares are listed on the NYSE under the ticker GL.
Globe Life’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 68.4, in the Accumulation zone, up 8.3 points over five sessions.
Up 8.3 points over five sessions.
Reading for Sep 28, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 20 | −5.0% | −3.9% | ||
| Accumulation (current zone) | 166 | +1.3% | +1.7% | ||
| Neutral | 413 | +0.4% | +1.9% | ||
| Distribution | 69 | −0.1% | +1.3% | ||
| Selling | 4 | Too few readings yet | |||
Average GL share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Globe Life trades 8.9% below Gekko Fair Value of $183.03, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Globe Life shares are worth, recalculated every trading day.
$183.03
Gekko Fair Value, Sep 29, 2026
8.9% Undervalued
No open-market insider purchases were filed for Globe Life, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for GL in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in GL were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Globe Life has been buying back its own shares.
From company filings.
1of the funds Gekko tracks holds GL.
Globe Life reports on Oct 28, 2026 (29 days away), and beat the EPS estimate in 5 of its last 8 reports.
Oct 28, 2026
29 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Apr 22, 2026 | $3.43 est $3.48 | $1.56B est $1.56B | +2.0% |
| Feb 4, 2026 | $3.39 est $3.44 | $1.52B est $1.53B | +2.3% |
| Oct 22, 2025 | $4.81 est $4.60 | $1.51B est $1.52B | −0.2% |
| Jul 23, 2025 | $3.27 est $3.25 | $1.48B est $1.51B | +7.1% |
| Apr 30, 2025 | $3.07 est $3.23 | $1.48B est $1.49B | −5.0% |
| Feb 5, 2025 | $3.14 est $3.12 | $1.47B est $1.48B | −2.0% |
| Oct 23, 2024 | $3.49 est $3.06 | $1.46B est $1.46B | −1.5% |
| Jul 24, 2024 | $2.97 est $2.91 | $1.44B est $1.45B | −0.5% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Globe Life is $193.91, +16.3% from the last close, from 9 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 9 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Aug 31 | TD Cowen | $225 | +35.0% |
| Jul 28 | BMO Capital | $192 | +15.2% |
| Jul 24 | Truist Financial | $185 | +11.0% |
| Jul 24 | Piper Sandler | $200 | +20.0% |
| Jul 24 | KBW | $190 | +14.0% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Sep 29, Globe Life averaged +2.1% across the last 5 years, rising in 4 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +1.7% | 4 of 5 |
| Next 10 trading days | +3.4% | 4 of 5 |
| Next 15 trading days | +3.9% | 4 of 5 |
| Next 20 trading days | +2.1% | 4 of 5 |
| Next 30 trading days | +4.2% | 4 of 5 |
For scale, GL’s typical 20-trading-day move in either direction is about 3.5%.
Globe Life’s market cap is $12.94B, with a P/E ratio of 11.1 and revenue of $6.19B over the last twelve months.
Coverage of Globe Life this week reads neutral: 3 positive, 8 neutral and 3 negative headlines.
Globe Life’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| PGRProgressive | Accumulation | 5.2% below |
| MFCManulife Financial | Neutral | 8.8% above |
| METMetLife | Neutral | 4.2% below |
| ALLAllstate | Buying | 13.8% below |
| AFLAFLAC | Accumulation | 4.8% below |
| SLFSun Life Financial | Neutral | 7.1% above |
A peer links to its own page where one exists.
Globe Life’s market cap is $12.94B at the Sep 28, 2026 close of $166.69, with 76.85M shares outstanding. The shares trade on a P/E ratio of 11.1.
The consensus analyst 12-month price target for Globe Life is $193.91, +16.3% from the last close. Of the 9 firms that rated the stock in the last 90 days, 7 rate it a buy, 2 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Globe Life is undervalued: the Sep 28, 2026 close of $166.69 is 8.9% below Gekko Fair Value of $183.03. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Globe Life is expected to report on Oct 28, 2026 (29 days away). Analysts expect earnings of $4.89 per share on revenue of $1.56B. Globe Life beat the earnings estimate in 5 of its last 8 reports, moving 2.6% on average across the report.
Globe Life’s 52-week high is $191.55 and its 52-week low is $127.85; it closed at $166.69 on Sep 28, 2026, +16.5% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 5 items with data read as supportive (gekkoindex, fair value, earnings risk and seasonality), 1 as mixed (trend). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.